NY S5314: Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy Verified

Bill S5314 establishes a Medicaid identification and anti-fraud biometric technology pilot program in New York by adding Article 2-B to the Public Health Law. The program mandates the use of biometric technology, which includes DNA, finger imaging, and other biological data, for authenticating Medicaid recipients and providers. The Department of Health, in consultation with the Medicaid Inspector General and Attorney General, will develop a request for proposals to implement this technology. The program requires Medicaid recipients to provide biometric proof of identity at healthcare visits, with provisions for emergency services and alternate identification methods. The program must be revenue neutral, aiming to reduce Medicaid expenditures through fraud elimination. Two pilot programs will be established, one in an upstate and one in a downstate hospital, each receiving $300,000 in funding. The bill appropriates $600,000 for the program's implementation. The bill does not specify penalties for non-compliance.